17/04/2003
London, UK – 17 April 2003: ReGen Therapeutics Plc (‘ReGen’ or the ‘Company’) announces that it has today placed 20,000,000 new ordinary shares (‘New Shares’) with new and existing shareholders at 0.75p per share raising the Company £150,000 for general working capital purposes.
Application will be made for the New Shares to be admitted to the Alternative Investment Market of the London Stock Exchange plc and dealings are expected to commence at 8.00 am on 25 April 2003.
Executive Chairman Percy Lomax said, ‘This fundraising, as part of our continuing fundraising efforts, illustrates the continued support for the Company in these very difficult market conditions. It will help, along with our recently acquired investment trust shares, to provide funding for our ongoing development programme. We also now continue to explore further fundraising and acquisition opportunities.’
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033